WNK2 and atherosclerosis: And it has been demonstrated that mitogen-activated protein kinase (MAPK) may play a role in anti-atherosclerosis [24-29], and moreover alogliptin can inhibit the ERK-mediated expression of matrix metalloproteinases, which are involved in atherosclerosis [17,30].